Optimal timing maximises Paxlovid benefits for treating COVID-19
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.
The findings suggest that taking Paxlovid three to five days after COVID-19 symptoms emerge may maximise the drug's ability to reduce viral loads, minimise viral spread and reduce viral rebound. (Source: World Pharma News)
Source: World Pharma News - April 23, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
ALGORAE Pharma Announces New Securities Issue
Living Cell Technologies Ltd. (AU:1AI) has released an update. ALGORAE PHARMACEUTICALS LIMITED has announced a new proposal to issue 1,000,000 ordi... (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2024 Category: Consumer Health News Source Type: news
Providence to pay over $200 million for wage violations
A class-action lawsuit alleged Providence shortchanged workers through unfair timekeeping and withholding meal breaks. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2024 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news
How the secret of sleep keeps us awake
Businesses can keep exploiting our tiredness while scientists seek to explain the mechanics of it (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 23, 2024 Category: Pharmaceuticals Source Type: news
Ogilvy forms health influencer unit to target ‘new frontier’ in marketing
WPP-owned advertising agency seeks to tap trend for seeking medical information on social media (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 23, 2024 Category: Pharmaceuticals Source Type: news
Aetna ’s big win: What to know as the State Health Plan transition draws near
Beginning in 2025, Aetna will replace Blue Cross Blue Shield as North Carolina ’s new State Health Plan (SHP) administrator. Jim Bostian, president of Aetna’s North Carolina market, and Sam Watts, executive director of the State Health Plan, respond to questions about the transition below.
Jim Bostian: Yes, I’m happy to. Beginning Jan. 1, 2025, Aetna will be the thi rd-party administrator for the State Health Plan. We will process medical claims, deliver member services and manage the health… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2024 Category: Pharmaceuticals Authors: Aetna Source Type: news
Pacific Mind Health Offers Comprehensive Depression Treatment Services in Southern California
Pacific Mind Health, a leading Southern California depression treatment center, prioritizes comprehensive mental health services for conditions like depression, anxiety, ADHD, and bipolar disorder. With cutting-edge treatments such as transcranial magnetic stimulation and ketamine... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2024 Category: Pharmaceuticals Source Type: news
Legal battle between Soin family and Kettering Health enters new phase (Update)
The ongoing legal battle between one of Dayton ’s most well-known families and a major health system in town is continuing with new allegations and denials from both sides. New counterclaims have been filed in the case. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 23, 2024 Category: Pharmaceuticals Authors: Lauren Steen Source Type: news
Firebrick Pharma Launches Nasodine in the US
Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has launched its nasal antiseptic/disinfectant, Nasodine, in the...#fre (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2024 Category: Consumer Health News Source Type: news
Pandemic Had Modest Effect on Early Childhood Development Milestones
MONDAY, April 22, 2024 -- Modest changes were seen in early childhood development milestone achievement during the COVID-19 pandemic, according to a study published online April 22 in JAMA Pediatrics.Sara B. Johnson, Ph.D., M.P.H., from the Johns... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2024 Category: Pharmaceuticals Source Type: news
Higher SaFETy Scores ID Increased Prevalence of Firearm Violence
MONDAY, April 22, 2024 -- The SaFETy score, a clinical screening tool specific to firearm violence, can identify young adults with past six-month firearm violence, according to a research letter published online April 23 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2024 Category: Pharmaceuticals Source Type: news
Hospital Mortality Lower for Patients Treated by Female Physicians
MONDAY, April 22, 2024 -- Patients have lower hospital mortality and readmission rates when treated by female physicians, with a larger benefit observed for female patients, according to a study published online April 23 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2024 Category: Pharmaceuticals Source Type: news
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
MONDAY, April 22, 2024 -- The U.S. Food and Drug Administration has approved Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2024 Category: Pharmaceuticals Source Type: news
Rubedo Life Sciences raise $40 million
With Silicon Valley obsessed with anti-aging, it is the latest startup to enter that market. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 22, 2024 Category: Pharmaceuticals Authors: Andrew Mendez Source Type: news
The search for useful proteins: Berkeley startup aims to turn generative AI into a gene-fixing tool
The Berkeley company's origins are in a brainstorming project five years ago at Salesforce. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 22, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
